[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NZ612185A - Topical combination formulations of macrocyclic lactones with synthetic pyrethroids - Google Patents

Topical combination formulations of macrocyclic lactones with synthetic pyrethroids

Info

Publication number
NZ612185A
NZ612185A NZ612185A NZ61218511A NZ612185A NZ 612185 A NZ612185 A NZ 612185A NZ 612185 A NZ612185 A NZ 612185A NZ 61218511 A NZ61218511 A NZ 61218511A NZ 612185 A NZ612185 A NZ 612185A
Authority
NZ
New Zealand
Prior art keywords
pyrethroid
macrocyclic lactone
macrocyclic lactones
combination formulations
synthetic pyrethroids
Prior art date
Application number
NZ612185A
Inventor
Robert Holmes
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Priority to NZ627856A priority Critical patent/NZ627856A/en
Publication of NZ612185A publication Critical patent/NZ612185A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Dermatology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Disclosed is a pharmaceutically or veterinarily acceptable formulation adapted to be topically applied to an animal, which formulation comprises; a) an effective amount of the pyrethroid deltamethrin; b) an effective amount of at least one macrocyclic lactone which is eprinomectin; c) a pharmaceutically acceptable system of solvents and/or suspending agents and excipients wherein the system provides for acceptable storage stability for both the pyrethroid and the macrocyclic lactone; wherein the macrocyclic lactone and the pyrethroid are both dissolved in a solvent (such as propylene glycol dicaprylate/dicaprate (MIGLYOL 840)), or, wherein the macrocyclic lactone is dissolved in an organic solvent (such as propylene glycol) and the pyrethroid is suspended in an aqueous phase; and wherein the system provides storage stability for greater than 3 months.
NZ612185A 2010-12-07 2011-12-06 Topical combination formulations of macrocyclic lactones with synthetic pyrethroids NZ612185A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ627856A NZ627856A (en) 2010-12-07 2011-12-06 Topical combination formulations of macrocyclic lactones with synthetic pyrethroids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42074410P 2010-12-07 2010-12-07
PCT/US2011/063497 WO2012078605A1 (en) 2010-12-07 2011-12-06 Topical combination formulations of macrocyclic lactones with synthetic pyrethroids

Publications (1)

Publication Number Publication Date
NZ612185A true NZ612185A (en) 2015-10-30

Family

ID=45464088

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ612185A NZ612185A (en) 2010-12-07 2011-12-06 Topical combination formulations of macrocyclic lactones with synthetic pyrethroids
NZ627856A NZ627856A (en) 2010-12-07 2011-12-06 Topical combination formulations of macrocyclic lactones with synthetic pyrethroids

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ627856A NZ627856A (en) 2010-12-07 2011-12-06 Topical combination formulations of macrocyclic lactones with synthetic pyrethroids

Country Status (3)

Country Link
AU (1) AU2011338573B2 (en)
NZ (2) NZ612185A (en)
WO (1) WO2012078605A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104483426A (en) * 2014-11-27 2015-04-01 黑龙江省乳品工业技术开发中心 Predicting method of reduction of content of acetochlor in lactation of dairy cattle and application
WO2016139331A1 (en) 2015-03-05 2016-09-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of melanoma
WO2017144546A1 (en) 2016-02-23 2017-08-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of nasopharyngeal carcinoma
EP3956446A1 (en) 2019-04-17 2022-02-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of nlrp3 inflammasome mediated il-1beta dependent disorders
EP3760045A1 (en) * 2019-07-04 2021-01-06 Laboratorios Virbac Mexico SA DE CV Topical composition against rhipicephalus (boophilus) microplus
WO2021198511A1 (en) 2020-04-03 2021-10-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of sars-cov-2 infection
WO2022008597A1 (en) 2020-07-08 2022-01-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical composition for the treatment of infectious diseases

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
SE434277B (en) 1976-04-19 1984-07-16 Merck & Co Inc SET TO MAKE NEW ANTIHELMINTICALLY EFFECTIVE ASSOCIATIONS BY CULTIVATING STREPTOMYCS AVERMITILIS
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
EP0237482A1 (en) 1986-03-06 1987-09-16 Ciba-Geigy Ag Derivatives of C(29)-carbonyloxy-milbemycine against parasites in animals and plants
AR243191A1 (en) 1986-03-25 1993-07-30 Sankyo Co A procedure for preparing macrolide compounds.
EP0252879B1 (en) 1986-07-02 1992-05-06 Ciba-Geigy Ag Pesticides
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
EP0319142B1 (en) 1987-11-03 1994-04-06 Beecham Group Plc Intermediates for the preparation of anthelmintic macrolide antibiotics
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
US5602107A (en) 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
ES2359973T3 (en) 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. LIQUID POLYMER COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES.
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
CN1237342A (en) * 1999-05-26 1999-12-08 解俊峰 Avermectin or ivermectin and high-effective chlorocyanogen micro emulsion
AU2003101020A4 (en) 1999-06-04 2004-01-29 Argenta Manufacturing Limited Stable Biocidal Compositions
EG23124A (en) 2001-02-27 2004-04-28 Syngenta Participations Ag Avermectins substituted in the 4-position having pesticidal properties
CR6574A (en) 2001-02-27 2004-10-28 Syngenta Participations Ag SALTS OF SUBSTITUTED FINDINGS IN POSITION 4 WITH PESTICIATED PROPERTIES
CN1386419A (en) * 2001-05-22 2002-12-25 王玉万 Composite insecticide containing macrolide insect repellents for sanitary purpose
BR0102126A (en) * 2001-05-25 2003-02-04 Vallee S A Synergistic combination of topical or injectable antiparasitics
AR036486A1 (en) 2001-08-28 2004-09-15 Syngenta Participations Ag DERIVATIVES 4 "-DESOXI-4" - (S) -AMINO AVERMECTINA, PESTICIDE COMPOSITION, PROCEDURE FOR THE PREPARATION OF THAT COMPOSITION, METHOD FOR CONTROLLING PESTS, AND USE OF THESE DERIVATIVES TO PREPARE A COMPOSITION
TW200301079A (en) 2001-12-21 2003-07-01 Syngenta Participations Ag Avermectin B1 derivatives having an aminosulfonyloxy substituent in the 4"-position
NZ520295A (en) 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
GB0302310D0 (en) 2003-01-31 2003-03-05 Syngenta Participations Ag Avermectin- and avermectin monosaccharide derivatives substituted in the 4"- or 4' - positionhaving pesticidal properties
GB0302308D0 (en) 2003-01-31 2003-03-05 Syngenta Participations Ag Avermectin and avermectin monosaccharide derivatives substituted in the 4"- or 4'-position having pesticidal properties
GB0313937D0 (en) 2003-06-16 2003-07-23 Syngenta Participations Ag Avermectin B1 monosaccharide derivatives having an aminosulfonyloxy substituentin the 4'-position
GB0320176D0 (en) 2003-08-28 2003-10-01 Syngenta Participations Ag Avermectins and avermectin monosaccharides substitued in the 4'-and 4"-positionhaving pesticidal properties
BRPI0506279B1 (en) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda SYNERGY COMPOSITION OF ANTIHELMINTICS AND NON-DECATED
CN101156588B (en) * 2007-11-19 2011-05-18 广西田园生化股份有限公司 Compound agricultural chemical
CN101518256A (en) * 2008-02-27 2009-09-02 潘贞德 A set of soluble liquid insecticides with cyfluthrin and highly efficient cyfluthrin as raw materials

Also Published As

Publication number Publication date
AU2011338573B2 (en) 2016-07-28
NZ627856A (en) 2016-03-31
WO2012078605A1 (en) 2012-06-14
AU2011338573A1 (en) 2013-07-11

Similar Documents

Publication Publication Date Title
NZ612185A (en) Topical combination formulations of macrocyclic lactones with synthetic pyrethroids
BR112012030653A2 (en) storage stable, substantially anhydrous topical aerosol composition and pressurized container
CA2864118A1 (en) Formulations of bendamustine
CY1122838T1 (en) TOPICAL COMPOSITIONS INCLUDING FIPRONIL AND PERMETHRIN AND METHODS OF USE
BR112015019657A2 (en) topical compositions and methods of use thereof
MX2010004222A (en) Solid formulations of crystalline compounds.
CO7240372A2 (en) Topical non-aqueous pharmaceutical formulations
ES2554245T3 (en) Injectable parasiticidal formulations of levamisole and macrocyclic lactones
EA200702593A1 (en) HIGHLY CONCENTRATED COMPOSITIONS APPLICABLE FOR THE FIGHT AGAINST ECO AND END-PARASITES
TW200716202A (en) Pediatric formulation of topiramate
BR112016002915A2 (en) sprayable agrochemical formulation, concentrated formulation, use of a c3 to c8 polyol fatty ester, or oligomer thereof, and methods for reducing spray drift and for treating vegetation to control pests and / or provide nutrients
WO2010030821A3 (en) Ibuprofen for topical administration
WO2006127399A3 (en) Versatile high load concentrate compositions comprising metaflumizone for control of ecto-parasites
RU2016103753A (en) TREATMENT OF INFLAMMATORY DAMAGES DURING ROSATION BY IVERMECTIN
BR112013008324B8 (en) compositions to control the psyllids trioza erytreae and diaphorina citri, vectors of bacteria of the genus candidatus liberibacter, which cause the most serious known citrus disease, namely huanglongbing (hlb)
WO2011035158A3 (en) Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria
MX2016008136A (en) Low voc gibberellin formulations.
WO2015048757A3 (en) Foam formulations and apparatus for delivery
WO2014178789A9 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
WO2011076209A3 (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
HUP0202823A2 (en) Topical organic ectoparasiticidal formulations
WO2014169003A3 (en) Multi-functional composition for cosmetic formulations
GR1006833B (en) Pesticidal composition.
PH12014501384A1 (en) Antibiotic formulations
WO2012029076A3 (en) Stable pharmaceutical composition

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: MERIAL, INC., US

Effective date: 20151022

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 06 DEC 2018 BY FB RICE

Effective date: 20160202

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 DEC 2019 BY COMPUTER PACKAGES INC

Effective date: 20181120

ASS Change of ownership

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC., US

Effective date: 20190328

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 DEC 2020 BY COMPUTER PACKAGES INC

Effective date: 20191203

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 DEC 2021 BY COMPUTER PACKAGES INC

Effective date: 20201118

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 DEC 2022 BY DENNEMEYER + CO

Effective date: 20211129

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 DEC 2023 BY DENNEMEYER + CO.

Effective date: 20221129

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 DEC 2024 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20231127